IOL Chemicals and Pharmaceuticals Limited — Financials & Forensics
NSE: IOLCP · BSE: 524164 · ISIN: INE485C01029
08 May 2026
FY26 headline numbers
| Line item | FY26 |
|---|---|
| Revenue from operations | ₹2,319 Cr |
| EBITDA | ₹258 Cr |
| EBITDA margin | 11.1% |
| Profit after tax | ₹138 Cr |
Deeper analysis
See IOL Chemicals and Pharmaceuticals Limited's full quarterly & annual history
Last 20 quarters of P&L · 7-year balance sheet · cash flow · shareholding pattern · concall transcripts & audio summaries · insider-trade history · bulk & block deals — all behind a free sign-up.
Sign up free →About IOL Chemicals and Pharmaceuticals Limited on Indian Stock Alerts
Indian Stock Alerts tracks IOL Chemicals and Pharmaceuticals Limited's SEBI / exchange filings in real time. Every quarterly result, audited annual report, shareholding pattern update, insider trade and corporate announcement is automatically parsed and surfaced as a structured data point — with a link back to the underlying filing.
Data points refreshed daily include closing price, 1Y change, market cap, P/E, ROE, dividend yield, RPT volume, audit / governance / accrual flags. Quarterly results numbers refresh within minutes of the company filing them with BSE / NSE.